AZO GANTRISIN
LOE ApproachingNDAORALTABLET
Approved
Aug 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AZO GANTRISIN is an oral tablet small-molecule combination product approved by Roche in 1990 for treating urinary tract infections and related conditions. The exact mechanism of action and pharmacologic class are not publicly detailed in this dataset, but the product name suggests a sulfonamide-based formulation. It represents a legacy therapeutic approach to bacterial urinary infections.
LOE Approaching
Product is in advanced lifecycle stage with competitive pressure at 30/100, indicating a mature/commoditized market with limited growth opportunities and likely lean commercial teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
AZO GANTRISIN currently shows zero linked job openings, reflecting its lifecycle stage and commoditized market position. Career opportunities on this asset are limited and focused on managing decline rather than growth, with roles primarily in regulatory compliance and legacy brand maintenance.
Brand Manager (legacy/generic transition)Field Sales Representative
Worked on AZO GANTRISIN at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.